Martin K Johnson
Overview
Explore the profile of Martin K Johnson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
557
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Panagiotou M, Vogiatzis I, Jayasekera G, Louvaris Z, Mackenzie A, McGlinchey N, et al.
Clin Physiol Funct Imaging
. 2017 Feb;
38(2):254-260.
PMID: 28168802
Background: Non-invasive methods of measuring cardiac output are highly desirable in pulmonary arterial hypertension (PAH). We therefore sought to validate impedance cardiography (ICG) against thermodilution (TD) and cardiac magnetic resonance...
12.
Panagiotou M, Church A, Johnson M, Peacock A
Eur Respir Rev
. 2017 Jan;
26(143).
PMID: 28096284
Pulmonary vascular and cardiac impairment is increasingly appreciated as a major adverse factor in the natural history of interstitial lung disease. This clinically orientated review focuses on the current concepts...
13.
Panagiotou M, Vogiatzis I, Louvaris Z, Jayasekera G, McKenzie A, McGlinchey N, et al.
Eur Respir J
. 2017 Jan;
49(1).
PMID: 28052962
No abstract available.
14.
Panagiotou M, Vogiatzis I, Louvaris Z, Jayasekera G, Mackenzie A, McGlinchey N, et al.
Eur Respir J
. 2016 Sep;
48(4):1224-1227.
PMID: 27587562
No abstract available.
15.
Brewis M, Bellofiore A, Vanderpool R, Chesler N, Johnson M, Naeije R, et al.
Int J Cardiol
. 2016 May;
218:206-211.
PMID: 27236116
Background: Right ventricular (RV) function is a major determinant of outcome in pulmonary arterial hypertension (PAH). However, uncertainty persists about the optimal method of evaluation. Methods: We measured RV end-systolic...
16.
Panagiotou M, Peacock A, Johnson M
Pulm Circ
. 2015 Sep;
5(3):424-34.
PMID: 26401245
Respiratory and limb muscle dysfunction is emerging as an important pathophysiological abnormality in pulmonary arterial hypertension (PAH). Muscle abnormalities appear to occur frequently and promote dyspnea, fatigue, and exercise limitation...
17.
Brewis M, Church A, Johnson M, Peacock A
Eur Respir J
. 2015 Aug;
46(5):1378-89.
PMID: 26293503
Pulmonary hypertension (PH) due to lung disease (World Health Organization (WHO) group 3) is common, but severe PH, arbitrarily defined as mean pulmonary artery pressure ≥35 mmHg is reported in...
18.
Brewis M, Church A, Peacock A, Thomson S, Tighe J, Johnson M
Pulm Circ
. 2015 Jan;
4(4):732-5.
PMID: 25610609
Pulmonary hypertension (PH) is defined by the presence of a mean pulmonary artery pressure (mPAP) ≥25 mmHg. It may be idiopathic or arise as a consequence of a number of...
19.
McGlinchey N, Johnson M
Biomark Med
. 2014 Oct;
8(8):1001-11.
PMID: 25343672
Pulmonary arterial hypertension (PAH) remains a difficult-to-treat condition with high mortality. Biomarkers are utilized to aid with diagnosis, prognostication and response to treatment. A clinically useful and PAH-specific single biomarker...
20.
Crawley S, Johnson M, Dargie H, Peacock A
JACC Cardiovasc Imaging
. 2013 Oct;
6(10):1120-1121.
PMID: 24135327
No abstract available.